Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Clarus
CLAR
$123M
| $10.7M | 0.01% |
916,704
-68,597
| -7% | -$851K |
|
1352
National CineMedia
NCMI
$376M
| $10.7M | 0.01% |
130,365
+32,282
| +33% | +$2.41M |
|
1353
British American Tobacco
BTI
$131B
| $10.7M | 0.01% |
289,234
-96,100
| -25% | -$3.52M |
|
|
ORC
1354
Orchid Island Capital
ORC
$1.3B
| $10.6M | 0.01% |
370,359
+134,200
| +57% | +$4.07M |
|
1355
John Wiley & Sons Class A
WLY
$2.65B
| $10.6M | 0.01% |
242,100
+27,000
| +13% | +$1.2M |
|
|
TIVO
1356
DELISTED
Tivo Inc
TIVO
| $10.6M | 0.01% |
1,394,635
-133,900
| -9% | -$1.02M |
|
1357
Churchill Downs
CHDN
$5.88B
| $10.6M | 0.01% |
171,850
-44,462
| -21% | -$2.68M |
|
1358
Dominion Energy
D
$60.8B
| $10.6M | 0.01% |
130,200
+124,245
| +2,086% | +$9.61M |
|
|
WW
1359
DELISTED
WW International
WW
| $10.5M | 0.01% |
278,512
-1,326,688
| -83% | -$37.5M |
|
1360
Digi International
DGII
$2.63B
| $10.5M | 0.01% |
772,884
+2,500
| +0.3% | +$32.9K |
|
|
UMPQ
1361
DELISTED
Umpqua Holdings Corp
UMPQ
| $10.5M | 0.01% |
638,888
-541,100
| -46% | -$8.89M |
|
|
MCHB
1362
Mechanics Bancorp
MCHB
$3.72B
| $10.5M | 0.01% |
383,800
+131,300
| +52% | +$3.64M |
|
|
CBM
1363
DELISTED
Cambrex Corporation
CBM
| $10.5M | 0.01% |
176,200
+109,500
| +164% | +$5.86M |
|
|
CEL
1364
DELISTED
Cellcom Israel, Ltd.
CEL
| $10.5M | 0.01% |
3,767,977
+16,100
| +0.4% | +$41.7K |
|
1365
Banco Macro
BMA
$5.88B
| $10.5M | 0.01% |
401,700
+162,000
| +68% | +$7.56M |
|
|
CERN
1366
DELISTED
Cerner Corp
CERN
| $10.4M | 0.01% |
+153,104
| New | +$10.8M |
|
|
CMBT
1367
CMB.TECH NV
CMBT
$4.69B
| $10.4M | 0.01% |
1,135,412
-480,292
| -30% | -$4.07M |
|
1368
Digital Realty Trust
DLR
$69.7B
| $10.4M | 0.01% |
80,143
-8,700
| -10% | -$1.06M |
|
1369
Suncor Energy
SU
$79.4B
| $10.4M | 0.01% |
328,940
-2,322,306
| -88% | -$69.9M |
|
1370
Park National Corp
PRK
$3.76B
| $10.4M | 0.01% |
109,400
-17,005
| -13% | -$1.6M |
|
|
BBBY
1371
DELISTED
Bed Bath & Beyond Inc
BBBY
| $10.4M | 0.01% |
973,660
-3,472,900
| -78% | -$33.5M |
|
1372
Sierra Bancorp
BSRR
$528M
| $10.4M | 0.01% |
389,831
+8,200
| +2% | +$211K |
|
1373
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
| $10.3M | 0.01% |
101,400
-29,100
| -22% | -$2.96M |
|
1374
Dover
DOV
$27.6B
| $10.3M | 0.01% |
103,600
-324,900
| -76% | -$31.2M |
|
1375
Quest Diagnostics
DGX
$25.7B
| $10.3M | 0.01% |
+96,300
| New | +$9.89M |
|
Similar funds
Renaissance Technologies's Q3 2019 Portfolio in Review
As of Q3 2019, Renaissance Technologies held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Renaissance Technologies's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Renaissance Technologies added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Renaissance Technologies's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Renaissance Technologies fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Renaissance Technologies's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Renaissance Technologies opened 406 new positions and closed 522 in Q3 2019.
- Renaissance Technologies's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.